MMR vaccine (Merck)

Measles-Mumps-Rubella vaccine · Merck & Co., Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MMR vaccine (Merck), covering 2018-07-03 to 2018-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age [Phase 3]

See pricing